Replies to post #582393 on $Stock*Shop*Charts*News*Option$

[EZ2]

BRIEF-Mylan CEO says it was never intended for patients to pay this price for Epipen-CNBC
REUTERS 8:57 AM ET 8/25/2016
Aug 25 (Reuters) - Mylan CEO on CNBC-

* Mylan CEO on her salary increasing as Epipen prices rose: "I understand...that facts are inconvenient to headlines"

* It was never intended for patients to pay this price for Epipen

* We are letting patients take control of price by using savings card

* I am legislating access to Epipen ; says the system is broken

* If Epipen price reduced, we couldn't ensure everyone could have an epipen

* System incentivizes high price for drugs

* Says I have reached out to the senators

* On future price rises says we will continue to run a businees

* Says is ready to work with Congress

(c) Copyright Thomson Reuters 2016. Click For Restrictions - about.reuters.com/fulllegal.asp

[MiamiGent]

SAFM Sanderson Farms Inches Higher Pre-Bell as Q2 Profit Tops Street Mark, Revenues Miss
BY Midnight Trader — 8:42 AM ET 08/25/2016

http://stockcharts.com/h-sc/ui?s=SAFM

08:42 AM EDT, 08/25/2016 (MT Newswires) -- Sanderson Farms (SAFM), a poultry processing company, reported Thursday Q2 net profit of $2.42 per share, up from $2.27 per share in the prior year period and higher than the $2.23 per share Street estimate provided by Capital IQ.
Net sales were $728 million, down from $739.9 million reported for the same period last year and lower than the $740.9 million Street estimate.
Shares were marginally higher pre-bell.
Price: 95.50, Change: +0.35, Percent Change: +0.37